Details for: SDCBP
Gene ID: 6386
Gene Type: Protein-coding - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.
Symbol: SDCBP
Ensembl ID: ENSG00000137575
Description: syndecan binding protein
Selected Context(s): Overall
Cell Significance Landscape
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 127.07rCSI 94.11%PRS 13.75
-
CSI 102.61rCSI 94.21%PRS 18.05
-
CSI 66.78rCSI 82.62%PRS 13.67
-
CSI 64.27rCSI 59.3%PRS 15.97
-
CSI 63.5rCSI 48.93%PRS 14.29
-
CSI 54.49rCSI 100%PRS 19.54
-
CSI 51.52rCSI 77.73%PRS 15.56
-
CSI 50.68rCSI 83.48%PRS 18.34
-
CSI 50.37rCSI 63.32%PRS 23.93
-
CSI 45.33rCSI 39.08%PRS 24.97
-
CSI 45.25rCSI 69.92%PRS 14.59
-
CSI 43.34rCSI 64.25%PRS 77.3
-
CSI 41.76rCSI 66.69%PRS 17.12
-
CSI 37.33rCSI 53.8%PRS 24.91
-
CSI 36.81rCSI 66.97%PRS 55.73
-
CSI 33.15rCSI 45.11%PRS 23.75
-
CSI 32.74rCSI 65.01%PRS 16.59
-
CSI 30.48rCSI 64.87%PRS 25.05
-
CSI 29.63rCSI 39.38%PRS 17.09
-
CSI 27.11rCSI 60.56%PRS 17.89
-
CSI 26.96rCSI 39.5%PRS 63.36
-
CSI 26.52rCSI 76.4%PRS 29.79
-
CSI 26.26rCSI 47.47%PRS 41.08
-
CSI 25.29rCSI 53.5%PRS 31.32
-
CSI 24.32rCSI 78.03%PRS 22.64
-
CSI 24.17rCSI 36.93%PRS 19.88
-
CSI 23.46rCSI 37.6%PRS 45.51
-
CSI 22.76rCSI 53.07%PRS 36.42
-
CSI 22.36rCSI 46.4%PRS 15.61
-
CSI 22rCSI 42.78%PRS 15.99
-
CSI 21.15rCSI 50.85%PRS 23.25
-
CSI 21.04rCSI 47.24%PRS 31.86
-
CSI 20.5rCSI 26.87%PRS 22.02
-
CSI 20.25rCSI 46.31%PRS 15.08
-
CSI 19.8rCSI 30.25%PRS 15.67
-
CSI 19.4rCSI 38.45%PRS 44.2
-
CSI 19.06rCSI 93.96%PRS 21.17
-
CSI 18.18rCSI 31.15%PRS 21.13
-
CSI 17.12rCSI 37.69%PRS 17.42
-
CSI 16.87rCSI 20.38%PRS 18.51
-
CSI 16.69rCSI 45.55%PRS 55.31
-
CSI 16.32rCSI 47.21%PRS 34.12
-
CSI 16.28rCSI 73.65%PRS 51.61
-
CSI 16.21rCSI 14.25%PRS 11.33
-
CSI 15.3rCSI 70.69%PRS 32.35
-
CSI 15.21rCSI 33.31%PRS 20.85
-
CSI 15.15rCSI 26.21%PRS 11.86
-
CSI 14.97rCSI 12.41%PRS 14.72
-
CSI 14.66rCSI 23.16%PRS 15.63
-
CSI 14.53rCSI 99.76%PRS 30.39
-
CSI 13.92rCSI 11.67%PRS 18.67
-
CSI 13.84rCSI 83.71%PRS 34.66
-
CSI 13.82rCSI 26.17%PRS 41.8
-
CSI 13.73rCSI 64.24%PRS 31.7
-
CSI 13.68rCSI 13.19%PRS 11.07
-
CSI 12.78rCSI 11.54%PRS 13.94
-
CSI 12.71rCSI 36.8%PRS 17.7
-
CSI 12.45rCSI 15.51%PRS 22.05
-
CSI 12.41rCSI 51.11%PRS 45.3
-
CSI 11.63rCSI 21.31%PRS 54.94
-
CSI 11.42rCSI 40.06%PRS 27.88
-
CSI 11.4rCSI 17.41%PRS 27.38
-
CSI 11.37rCSI 49.13%PRS 29.25
-
CSI 11.13rCSI 81.34%PRS 41.53
-
CSI 11.09rCSI 13.31%PRS 15.37
-
CSI 10.79rCSI 62.76%PRS 23.41
-
CSI 10.5rCSI 11%PRS 16.68
-
CSI 10.43rCSI 24.91%PRS 24
-
CSI 10.3rCSI 16.43%PRS 13.41
-
CSI 10.12rCSI 80.79%PRS 57.12
-
CSI 9.82rCSI 9.07%PRS 28.27
-
CSI 9.54rCSI 7.97%PRS 43.31
-
CSI 9.18rCSI 13.1%PRS 17.6
-
CSI 8.77rCSI 8.44%PRS 16.17
-
CSI 8.5rCSI 14.54%PRS 31.17
-
CSI 8.44rCSI 74.86%PRS 55.09
-
CSI 8.43rCSI 13.59%PRS 24.6
-
CSI 8.39rCSI 12.16%PRS 23.22
-
CSI 8.08rCSI 32.28%PRS 33.43
-
CSI 7.95rCSI 44.46%PRS 30.17
-
CSI 7.56rCSI 10.51%PRS 16.04
-
CSI 7.53rCSI 81.88%PRS 55.65
-
CSI 7.06rCSI 9.66%PRS 15.57
-
CSI 7.04rCSI 4.9%PRS 22.16
-
CSI 6.97rCSI 8.94%PRS 18.03
-
CSI 6.96rCSI 19.59%PRS 21.65
-
CSI 6.66rCSI 36.94%PRS 43.13
-
CSI 6.65rCSI 12%PRS 40
-
CSI 6.61rCSI 5.56%PRS 24.95
-
CSI 6.54rCSI 17.97%PRS 25.75
-
CSI 6.4rCSI 9.38%PRS 20.51
-
CSI 6.24rCSI 12.44%PRS 26.25
-
CSI 6.2rCSI 8.59%PRS 22.26
-
CSI 6.15rCSI 32.31%PRS 27.24
-
CSI 6.14rCSI 7.1%PRS 11.43
-
CSI 6.08rCSI 13.12%PRS 60.72
-
CSI 6.06rCSI 13.41%PRS 14.5
-
CSI 5.99rCSI 7.52%PRS 20.08
-
CSI 5.96rCSI 22.31%PRS 13.22
-
CSI 5.88rCSI 3.96%PRS 18.83
-
CSI -5.1rCSI -11.4%PRS 9.6%
-
CSI -4.4rCSI -5.2%PRS 20.9%
-
CSI -2.7rCSI -3.6%PRS 20.6%
-
CSI -1.9rCSI -7.2%PRS 22.0%
-
CSI -1.8rCSI -7.5%PRS 30.7%
-
CSI -1.8rCSI -2.4%PRS 29.7%
-
CSI -1.7rCSI -5.4%PRS 10.5%
-
CSI -1.7rCSI -3.1%PRS 12.8%
-
CSI -1.1rCSI -2.5%PRS 23.8%
-
CSI -0.8rCSI -5.3%PRS 12.2%
-
CSI -0.7rCSI -3.5%PRS 11.0%
-
CSI -0.7rCSI -3.0%PRS 15.0%
-
CSI -0.7rCSI -2.4%PRS 8.6%
-
CSI -0.5rCSI -8.0%PRS 55.0%
-
CSI -0.4rCSI -1.0%PRS 11.8%
-
CSI -0.3rCSI -2.1%PRS 8.4%
-
CSI -0.2rCSI -0.5%PRS 12.0%
-
CSI -0.1rCSI -0.2%PRS 10.0%
-
CSI 0.0rCSI 0.0%PRS 25.6%
-
CSI 0.1rCSI 0.2%PRS 55.6%
-
CSI 0.1rCSI 1.3%PRS 46.1%
-
CSI 0.1rCSI 0.4%PRS 9.4%
-
CSI 0.1rCSI 0.3%PRS 9.8%
-
CSI 0.1rCSI 0.6%PRS 50.5%
-
CSI 0.1rCSI 1.0%PRS 32.5%
-
CSI 0.1rCSI 2.8%PRS 68.2%
-
CSI 0.1rCSI 3.4%PRS 64.0%
-
CSI 0.1rCSI 0.2%PRS 14.5%
-
CSI 0.2rCSI 1.3%PRS 6.1%
-
CSI 0.2rCSI 1.0%PRS 22.8%
-
CSI 0.2rCSI 3.0%PRS 56.9%
-
CSI 0.2rCSI 0.2%PRS 32.0%
-
CSI 0.2rCSI 5.5%PRS 60.5%
-
CSI 0.3rCSI 1.4%PRS 9.7%
-
CSI 0.3rCSI 3.1%PRS 42.3%
-
CSI 0.3rCSI 1.5%PRS 36.0%
-
CSI 0.3rCSI 1.2%PRS 31.4%
-
CSI 0.3rCSI 0.6%PRS 9.2%
-
CSI 0.4rCSI 9.2%PRS 62.0%
-
CSI 0.4rCSI 0.3%PRS 19.4%
-
CSI 0.4rCSI 1.1%PRS 26.8%
-
CSI 0.4rCSI 1.1%PRS 12.9%
-
CSI 0.4rCSI 7.9%PRS 83.1%
-
CSI 0.4rCSI 1.1%PRS 20.4%
-
CSI 0.4rCSI 2.3%PRS 30.4%
-
CSI 0.4rCSI 1.7%PRS 21.6%
-
CSI 0.5rCSI 0.7%PRS 12.0%
-
CSI 0.5rCSI 5.2%PRS 21.1%
-
CSI 0.5rCSI 0.8%PRS 25.4%
-
CSI 0.5rCSI 2.4%PRS 15.3%
-
CSI 0.5rCSI 0.7%PRS 20.1%
-
CSI 0.6rCSI 1.4%PRS 43.7%
-
CSI 0.6rCSI 3.3%PRS 52.4%
-
CSI 0.6rCSI 0.9%PRS 17.9%
-
CSI 0.6rCSI 1.3%PRS 31.0%
-
CSI 0.7rCSI 3.3%PRS 20.5%
-
CSI 0.7rCSI 1.7%PRS 39.8%
-
CSI 0.7rCSI 1.8%PRS 25.4%
-
CSI 0.7rCSI 2.5%PRS 47.6%
-
CSI 0.7rCSI 0.9%PRS 9.7%
-
CSI 0.7rCSI 4.6%PRS 69.3%
-
CSI 0.7rCSI 2.0%PRS 14.5%
-
CSI 0.8rCSI 2.6%PRS 41.9%
-
CSI 0.8rCSI 2.2%PRS 56.8%
-
CSI 0.8rCSI 1.1%PRS 31.8%
-
CSI 0.8rCSI 2.6%PRS 16.5%
-
CSI 0.8rCSI 2.0%PRS 9.0%
-
CSI 0.8rCSI 2.2%PRS 30.4%
-
CSI 0.8rCSI 3.7%PRS 51.8%
-
CSI 0.9rCSI 0.5%PRS 21.6%
-
CSI 0.9rCSI 1.0%PRS 13.7%
-
CSI 0.9rCSI 2.1%PRS 24.8%
-
CSI 0.9rCSI 0.9%PRS 24.5%
-
CSI 0.9rCSI 1.0%PRS 31.8%
-
CSI 0.9rCSI 2.2%PRS 28.0%
-
CSI 0.9rCSI 2.4%PRS 24.3%
-
CSI 0.9rCSI 4.1%PRS 29.0%
-
CSI 1.0rCSI 2.0%PRS 25.8%
-
CSI 1.0rCSI 3.5%PRS 26.7%
-
CSI 1.0rCSI 1.7%PRS 14.5%
-
CSI 1.0rCSI 2.7%PRS 24.2%
-
CSI 1.1rCSI 5.2%PRS 68.9%
-
CSI 1.1rCSI 0.9%PRS 17.5%
-
CSI 1.1rCSI 8.8%PRS 16.0%
-
CSI 1.1rCSI 0.8%PRS 25.2%
-
CSI 1.1rCSI 2.3%PRS 23.5%
-
CSI 1.1rCSI 2.5%PRS 11.2%
-
CSI 1.2rCSI 2.3%PRS 34.9%
-
CSI 1.2rCSI 21.4%PRS 44.8%
-
CSI 1.3rCSI 1.8%PRS 14.2%
-
CSI 1.3rCSI 1.6%PRS 16.5%
-
CSI 1.3rCSI 2.3%PRS 9.2%
-
CSI 1.3rCSI 31.1%PRS 7.4%
-
CSI 1.4rCSI 1.4%PRS 28.9%
-
CSI 1.4rCSI 5.3%PRS 15.4%
-
CSI 1.4rCSI 41.8%PRS 35.0%
-
CSI 1.4rCSI 6.1%PRS 27.6%
-
CSI 1.5rCSI 2.3%PRS 37.1%
-
CSI 1.5rCSI 5.4%PRS 53.1%
-
CSI 1.5rCSI 1.6%PRS 16.3%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 4139229000
Symbol: SDCB1_HUMAN
Name: Syntenin-1
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 9391086
Title: Syntenin, a PDZ protein that binds syndecan cytoplasmic domains.
PubMed ID: 9391086
PubMed ID: 9511750
Title: Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene.
PubMed ID: 9511750
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
PubMed ID: 16421571
Title: DNA sequence and analysis of human chromosome 8.
PubMed ID: 16421571
DOI: 10.1038/nature04406
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 9883737
Title: PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands.
PubMed ID: 9883737
PubMed ID: 10230395
Title: A role for a PDZ protein in the early secretory pathway for the targeting of proTGF-alpha to the cell surface.
PubMed ID: 10230395
PubMed ID: 10770943
Title: Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin.
PubMed ID: 10770943
PubMed ID: 11152476
Title: The neural cell recognition molecule neurofascin interacts with syntenin-1 but not with syntenin-2, both of which reveal self-associating activity.
PubMed ID: 11152476
PubMed ID: 11432873
Title: Schwannomin isoform-1 interacts with syntenin via PDZ domains.
PubMed ID: 11432873
PubMed ID: 11179419
Title: Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments.
PubMed ID: 11179419
DOI: 10.1091/mbc.12.2.339
PubMed ID: 11498591
Title: Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein.
PubMed ID: 11498591
PubMed ID: 12643545
Title: Proteomic analysis of early melanosomes: identification of novel melanosomal proteins.
PubMed ID: 12643545
DOI: 10.1021/pr025562r
PubMed ID: 17081065
Title: Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.
PubMed ID: 17081065
DOI: 10.1021/pr060363j
PubMed ID: 19413330
Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.
PubMed ID: 19413330
DOI: 10.1021/ac9004309
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 22660413
Title: Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.
PubMed ID: 22660413
DOI: 10.1038/ncb2502
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
PubMed ID: 26032692
Title: Syntenin and syndecan in the biogenesis of exosomes.
PubMed ID: 26032692
PubMed ID: 25219541
Title: Targeting tumor invasion: the roles of MDA-9/Syntenin.
PubMed ID: 25219541
PubMed ID: 26539120
Title: Syntenin controls migration, growth, proliferation, and cell cycle progression in cancer cells.
PubMed ID: 26539120
PubMed ID: 25893292
Title: Syntenin regulates TGF-beta1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-beta type I receptor internalization.
PubMed ID: 25893292
DOI: 10.1038/onc.2015.100
PubMed ID: 26291527
PubMed ID: 12679023
Title: PDZ tandem of human syntenin: crystal structure and functional properties.
PubMed ID: 12679023
PubMed ID: 12842047
Title: Molecular roots of degenerate specificity in syntenin's PDZ2 domain: reassessment of the PDZ recognition paradigm.
PubMed ID: 12842047
PubMed ID: 15081807
Title: The PDZ2 domain of syntenin at ultra-high resolution: bridging the gap between macromolecular and small molecule crystallography.
PubMed ID: 15081807
PubMed ID: 16533050
Title: The binding of the PDZ tandem of syntenin to target proteins.
PubMed ID: 16533050
DOI: 10.1021/bi052225y
PubMed ID: 27386966
Title: Frizzled 7 and PIP2 binding by syntenin PDZ2 domain supports Frizzled 7 trafficking and signalling.
PubMed ID: 27386966
DOI: 10.1038/ncomms12101
Sequence Information:
- Length: 298
- Mass: 32444
- Checksum: 574E1349F86F949F
- Sequence:
MSLYPSLEDL KVDKVIQAQT AFSANPANPA ILSEASAPIP HDGNLYPRLY PELSQYMGLS LNEEEIRANV AVVSGAPLQG QLVARPSSIN YMVAPVTGND VGIRRAEIKQ GIREVILCKD QDGKIGLRLK SIDNGIFVQL VQANSPASLV GLRFGDQVLQ INGENCAGWS SDKAHKVLKQ AFGEKITMTI RDRPFERTIT MHKDSTGHVG FIFKNGKITS IVKDSSAARN GLLTEHNICE INGQNVIGLK DSQIADILST SGTVVTITIM PAFIFEHIIK RMAPSIMKSL MDHTIPEV
Genular Protein ID: 1783094541
Symbol: B4DHN5_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 11237011
Title: Initial sequencing and analysis of the human genome.
PubMed ID: 11237011
DOI: 10.1038/35057062
PubMed ID: 15496913
Title: Finishing the euchromatic sequence of the human genome.
PubMed ID: 15496913
DOI: 10.1038/nature03001
PubMed ID: 16421571
Title: DNA sequence and analysis of human chromosome 8.
PubMed ID: 16421571
DOI: 10.1038/nature04406
PubMed ID: 19413330
Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.
PubMed ID: 19413330
DOI: 10.1021/ac9004309
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
Sequence Information:
- Length: 239
- Mass: 25968
- Checksum: C8ECBFCEDF02B3A7
- Sequence:
MSLYPSLEDL KVDKVIQAQT AFSANPANPA ILSEASAPIP HDGNLYPRLY PELSQYMGLS LNEEEIRANV AVVSGAPLQG LVQANSPASL VGLRFGDQVL QINGENCAGW SSDKAHKVLK QAFGEKITMT IRDRPFERTI TMHKDSTGHV GFIFKNGKIT SIVKDSSAAR NGLLTEHNIC EINGQNVIGL KDSQIADILS TSGTVVTITI MPAFIFEHII KRMAPSIMKS LMDHTIPEV
Genular Protein ID: 3473848320
Symbol: G5EA09_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 11237011
Title: Initial sequencing and analysis of the human genome.
PubMed ID: 11237011
DOI: 10.1038/35057062
PubMed ID: 11181995
PubMed ID: 15496913
Title: Finishing the euchromatic sequence of the human genome.
PubMed ID: 15496913
DOI: 10.1038/nature03001
PubMed ID: 16421571
Title: DNA sequence and analysis of human chromosome 8.
PubMed ID: 16421571
DOI: 10.1038/nature04406
PubMed ID: 19413330
Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.
PubMed ID: 19413330
DOI: 10.1021/ac9004309
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
Sequence Information:
- Length: 318
- Mass: 34819
- Checksum: DEA5027C28090AFB
- Sequence:
MIKLWTNRDL HIIVMVKNPA KMSLYPSLED LKVDKVIQAQ TAFSANPANP AILSEASAPI PHDGNLYPRL YPELSQYMGL SLNEEEIRAN VAVVSGAPLQ GLVARPSSIN YMVAPVTGND VGIRRAEIKQ GIREVILCKD QDGKIGLRLK SIDNGIFVQL VQANSPASLV GLRFGDQVLQ INGENCAGWS SDKAHKVLKQ AFGEKITMTI RDRPFERTIT MHKDSTGHVG FIFKNGKITS IVKDSSAARN GLLTEHNICE INGQNVIGLK DSQIADILST SGTVVTITIM PAFIFEHIIK RMAPSIMKSL MDHTIPEV